A patient with HIV-1 superinfection

New England Journal of Medicine

Volumn 347, Issue 10, 2002, Pages 731-736

  Jost, Stephanie ^a   Bernard, Marie Charlotte ^a   Kaiser, Laurent ^a   Yerly, Sabine ^a   Hirschel, Bernard ^a   Samri, Assia ^b   Autran, Brigitte ^b   Goh, Li Ean ^c   Perrin, Luc ^a,d  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c GLAXOSMITHKLINE   (United Kingdom)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; LAMIVUDINE; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SUPERINFECTION; VIRUS DETECTION; VIRUS HEPATITIS; VIRUS INFECTION;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DNA, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; MALE; PHYLOGENY; POLYMERASE CHAIN REACTION; RNA, VIRAL; SUPERINFECTION;

EID: 0037026686     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa020263     Document Type: Article

References (17)

1. Korber B, Gaschen B, Yusim K, Thakallapally R, Kesmir C, Detours V. Evolutionary and immunological implications of contemporary HIV-1 variation. Br Med Bull 2001;58:19-42.
2. HIV sequence data base: the circulating recombinant forms (CRFs) of HIV-1. Los Alamos, N.M.: Los Alamos National Laboratory, 2002. (Also available at http://hiv-web.lan1.gov/CRFs/CRFs.html.)
3. Kampinga GA, Simonon A, Van de Perre P, Karita E, Msellati P, Goudsmit J. Primary infections with HIV-1 of women and their offspring in Rwanda: findings of heterogeneity at seroconversion, coinfection, and recombinants of HIV-1 subtypes A and C. Virology 1997;227:63-76.
4. Zhu T, Wang N, Carr A, Wolinsky S, Ho DD. Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconvertor. J Virol 1995;69:1324-7.
5. Malim MH, Emerman M. HIV-1 sequence variation: drift, shift, and attenuation. Cell 2001;104:469-72.
6. Angel JB, Kravcik S, Balaskas E, et al. Documentation of HIV-1 superinfection and acceleration of disease progression. In: Program and abstracts of the 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, January 30-February 2, 2000. San Francisco: Foundation for Retrovirology and Human Health, 2000:235. abstract.
7. Shibata R, Siemon C, Cho MW, et al. Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1.) J Virol 1996;70:4361-9.
8. Stephens EB, Joag SV, Atkinson B, et al. Infected macaques that controlled replication of SIVmac or nonpathogenic SHIV developed sterilizing resistance against pathogenic SHIV(KU-1). Virology 1997;234:328-39.
9. Stahl-Hennig C, Dittmer U, Nisslein T, et al. Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus.) J Gen Virol 1996;77:2969-81.
10. Goh LE, Perrin L, Hoen B, et al. Study protocol for the evaluation of the potential for durable viral suppression after quadruple HAART with or without HIV vaccination: the QUEST study. HIV Clin Trials 2001;2:438-44.
11. Clinical investigator's brochure, ALVAC(2) 120 (B,MN)GNP (vCP1452). Swiftwater, Pa.: Aventis Pasteur, 1999.
12. Yerly S, Quadri R, Negro F, et al. Nosocomial outbreak of multiple bloodborne viral infections. J Infect Dis 2001;184:369-72.
13. Yerly S, Vora S, Rizzardi P, et al. Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. AIDS 2001;15:2287-92.
14. Samri A, Haas G, Duntze J, et al. Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells. J Virol 2000;74:9306-12.
15. Felsenstein J. PHYLIP, Phylogeny Inference Package, version 3.6 (alpha). Seattle: Department of Genetics, University of Washington, 2001.
16. Farzadegan H, Henrard DR, Kleeberger CA, et al. Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:448-55.
17. Liu SL, Schacker T, Musey L, et al. Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses. J Virol 1997;71:4284-95.